Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vaccines

  Free Subscription

30.08.2021

13 BMJ
1 J Gen Virol
2 J Immunol
2 J Infect
3 J Pediatr
4 J Virol
1 Lancet
6 MMWR Morb Mortal Wkly Rep
7 N Engl J Med
2 Nat Immunol
2 Pediatr Infect Dis J
1 Pediatrics
10 PLoS One
5 Science
18 Vaccine



    BMJ

  1. KLUNGEL OH, Pottegard A
    Strengthening international surveillance of vaccine safety.
    BMJ. 2021;374:n1994.
    >> Share

  2. CHUNG H, He S, Nasreen S, Sundaram ME, et al
    Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study.
    BMJ. 2021;374:n1943.
    >> Share

  3. MARCHETTI F, Tamburlini G
    Other good reasons for covid-19 vaccination in pre-adolescent and adolescent populations.
    BMJ. 2021;374:n2052.
    >> Share

  4. MAHASE E
    Covid-19 booster vaccines: What we know and who's doing what.
    BMJ. 2021;374:n2082.
    >> Share

  5. RANZANI OT, Hitchings MDT, Dorion M, D'Agostini TL, et al
    Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study.
    BMJ. 2021;374:n2015.
    >> Share

  6. IACOBUCCI G
    Covid-19: FDA set to grant full approval to Pfizer vaccine without public discussion of data.
    BMJ. 2021;374:n2086.
    >> Share

  7. WADVALLA BA
    How South Africa is dragging its vaccine rollout back from the brink.
    BMJ. 2021;374:n1949.
    >> Share

  8. MAHASE E
    Covid-19 vaccines: GPs boost uptake by calling patients and teaming up with community groups.
    BMJ. 2021;374:n2093.
    >> Share

  9. HIPPISLEY-COX J, Patone M, Mei XW, Saatci D, et al
    Risk of thrombocytopenia and thromboembolism after covid-19 vaccination and SARS-CoV-2 positive testing: self-controlled case series study.
    BMJ. 2021;374:n1931.
    >> Share

  10. FEINMANN J
    How the world is (not) handling surplus doses and expiring vaccines.
    BMJ. 2021;374:n2062.
    >> Share

  11. IACOBUCCI G
    Covid-19: Protection from two doses of vaccine wanes within six months, data suggest.
    BMJ. 2021;374:n2113.
    >> Share

  12. MUNRO C
    Covid-19: 40% of patients with weakened immune system mount lower response to vaccines.
    BMJ. 2021;374:n2098.
    >> Share

  13. TANNE JH
    Covid-19: FDA approves Pfizer-BioNTech vaccine in record time.
    BMJ. 2021;374:n2096.
    >> Share


    J Gen Virol

  14. GUERRERO-ARGUERO I, Tellez-Freitas CM, Weber KS, Berges BK, et al
    Alphaviruses: Host pathogenesis, immune response, and vaccine & treatment updates.
    J Gen Virol. 2021;102.
    >> Share


    J Immunol

  15. STEPHENS LM, Ross KA, Waldstein KA, Legge KL, et al
    Prefusion F-Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus.
    J Immunol. 2021;206:2122-2134.
    >> Share

  16. SANGEWAR N, Waghela SD, Yao J, Sang H, et al
    Novel Potent IFN-gamma-Inducing CD8(+) T Cell Epitopes Conserved among Diverse Bovine Viral Diarrhea Virus Strains.
    J Immunol. 2021;206:1709-1718.
    >> Share


    J Infect

  17. WEISSMAN YL, Cooper L, Sternbach N, Ashkenazi-Hoffnung L, et al
    Clinical efficacy and safety of high dose trivalent influenza vaccine in adults and immunosuppressed populations -a systematic review and meta-analysis.
    J Infect. 2021 Aug 20. pii: S0163-4453(21)00417.
    >> Share

  18. TRE-HARDY M, Cupaiolo R, Wilmet A, Antoine-Moussiaux T, et al
    Six-month interim analysis of ongoing immunogenicity surveillance of the mRNA-1273 vaccine in healthcare workers: A third dose is expected.
    J Infect. 2021 Aug 23. pii: S0163-4453(21)00433.
    >> Share


    J Pediatr

  19. GRAY KJ
    Maternal COVID-19 vaccine antibody response and passage into cord blood.
    J Pediatr. 2021;236:325-328.
    >> Share

  20. LONG SS
    50 Years Ago in TheJournalofPediatrics: Early Lessons about Infectious Diseases and Vaccines in Children with Cancer.
    J Pediatr. 2021;236:130.
    >> Share

  21. SPRENGHOLZ P, Betsch C
    Zero-sum or worse? Considering detrimental effects of selective mandates on voluntary childhood vaccinations.
    J Pediatr. 2021 Aug 18. pii: S0022-3476(21)00779.
    >> Share


    J Virol

  22. SAUTTO GA, Ecker JW, Ross TM
    An H1N1 Computationally Optimized Broadly Reactive Antigen elicits a neutralizing antibody response against an emerging human-infecting Eurasian avian-like swine influenza virus.
    J Virol. 2021 Apr 14. pii: JVI.02421-20. doi: 10.1128/JVI.02421.
    >> Share

  23. LEAMAN DP, Stano A, Chen Y, Zhang L, et al
    Membrane Env liposomes facilitate immunization with multivalent full-length HIV spikes.
    J Virol. 2021 Apr 21. pii: JVI.00005-21. doi: 10.1128/JVI.00005.
    >> Share

  24. CASTRO IM, Ricciardi MJ, Gonzalez-Nieto L, Rakasz EG, et al
    Recombinant Herpesvirus Vectors: Durable Immune Responses and Durable Protection Against SIVmac239 Acquisition
    J Virol. 2021 Apr 28. pii: JVI.00330-21. doi: 10.1128/JVI.00330.
    >> Share

  25. FARRELL HE, Bruce K, Stevenson PG
    A live olfactory MCMV vaccine attenuated for systemic spread, protects against superinfection.
    J Virol. 2021 Aug 25:JVI0126421. doi: 10.1128/JVI.01264.
    >> Share


    Lancet

  26. SHROTRI M, Navaratnam AMD, Nguyen V, Byrne T, et al
    Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
    Lancet. 2021;398:385-387.
    >> Share


    MMWR Morb Mortal Wkly Rep

  27. ROSENBERG ES, Holtgrave DR, Dorabawila V, Conroy M, et al
    New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status - New York, May 3-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1150-1155.
    >> Share

  28. NANDURI S, Pilishvili T, Derado G, Soe MM, et al
    Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-Au
    MMWR Morb Mortal Wkly Rep. 2021;70:1163-1166.
    >> Share

  29. FOWLKES A, Gaglani M, Groover K, Thiese MS, et al
    Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1167-1169.
    >> Share

  30. TENFORDE MW, Self WH, Naioti EA, Ginde AA, et al
    Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1156-1162.
    >> Share

  31. GRIFFIN JB, Haddix M, Danza P, Fisher R, et al
    SARS-CoV-2 Infections and Hospitalizations Among Persons Aged >/=16 Years, by Vaccination Status - Los Angeles County, California, May 1-July 25, 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1170-1176.
    >> Share

  32. BIGOUETTE JP, Wilkinson AL, Tallis G, Burns CC, et al
    Progress Toward Polio Eradication - Worldwide, January 2019-June 2021.
    MMWR Morb Mortal Wkly Rep. 2021;70:1129-1135.
    >> Share


    N Engl J Med

  33. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Monoclonal Antibodies and Booster Shots.
    N Engl J Med. 2021;385:e29.
    >> Share

  34. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Aspects of Covid-19 Immunity.
    N Engl J Med. 2021;385:e31.
    >> Share

  35. LEE GM
    The Importance of Context in Covid-19 Vaccine Safety.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMe2112543.
    >> Share

  36. CHANDRAMOHAN D, Zongo I, Sagara I, Cairns M, et al
    Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2026330.
    >> Share

  37. BARDA N, Dagan N, Ben-Shlomo Y, Kepten E, et al
    Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMoa2110475.
    >> Share

  38. UZUN G, Althaus K, Bakchoul T
    No Correlation between Anti-PF4 and Anti-SARS-CoV-2 Antibodies after ChAdOx1 nCoV-19 Vaccination.
    N Engl J Med. 2021 Aug 25. doi: 10.1056/NEJMc2111305.
    >> Share

  39. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: Assessing Vaccine Safety.
    N Engl J Med. 2021;385:e37.
    >> Share


    Nat Immunol

  40. FEHERVARI Z
    Intranasal vaccination.
    Nat Immunol. 2021;22:1071.
    >> Share

  41. WOLYNN T, Hermann C
    Shots heard round the world: better communication holds the key to increasing vaccine acceptance.
    Nat Immunol. 2021;22:1068-1070.
    >> Share


    Pediatr Infect Dis J

  42. HANSEN J, Decker MD, Lewis E, Fireman B, et al
    Hypotonic-hyporesponsive Episodes After Diphtheria, Tetanus and Acellular Pertussis Vaccination.
    Pediatr Infect Dis J. 2021 Aug 20. pii: 00006454-900000000-95703.
    >> Share

  43. ZUMSTEIN J, Heininger U
    Clinical and Epidemiologic Characteristics of Pertussis in Hospitalized Children: A Prospective and Standardized Long-term Surveillance Study.
    Pediatr Infect Dis J. 2021;40:22-25.
    >> Share


    Pediatrics

  44. ROWE SL, Leder K, Perrett KP, Romero N, et al
    Maternal Vaccination and Infant Influenza and Pertussis.
    Pediatrics. 2021 Aug 26. pii: peds.2021-051076. doi: 10.1542/peds.2021-051076.
    >> Share


    PLoS One

  45. SALING LL, Mallal D, Scholer F, Skelton R, et al
    No one is immune to misinformation: An investigation of misinformation sharing by subscribers to a fact-checking newsletter.
    PLoS One. 2021;16:e0255702.
    >> Share

  46. HU W, DeMarcus LS, Sjoberg PA, Robbins AS, et al
    Inactivated influenza vaccine effectiveness among department of defense beneficiaries aged 6 months-17 years, 2016-2017 through 2019-2020 influenza seasons.
    PLoS One. 2021;16:e0256165.
    >> Share

  47. HOPKER A, Pandey N, Bartholomew R, Blanton A, et al
    Livestock vaccination programme participation among smallholder farmers on the outskirts of National Parks and Tiger Reserves in the Indian states of Madhya Pradesh and Assam.
    PLoS One. 2021;16:e0256684.
    >> Share

  48. FATIREGUN AA, Lochlainn LN, Kabore L, Dosumu M, et al
    Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
    PLoS One. 2021;16:e0252798.
    >> Share

  49. SOBUE T, Fukuda H, Matsumoto T, Lee B, et al
    The background occurrence of selected clinical conditions prior to the start of an extensive national vaccination program in Japan.
    PLoS One. 2021;16:e0256379.
    >> Share

  50. TRAVIS J, Harris S, Fadel T, Webb G, et al
    Identifying the determinants of COVID-19 preventative behaviors and vaccine intentions among South Carolina residents.
    PLoS One. 2021;16:e0256178.
    >> Share

  51. KRICORIAN K, Turner K
    COVID-19 Vaccine Acceptance and Beliefs among Black and Hispanic Americans.
    PLoS One. 2021;16:e0256122.
    >> Share

  52. KALAM MA, Davis TP Jr, Shano S, Uddin MN, et al
    Exploring the behavioral determinants of COVID-19 vaccine acceptance among an urban population in Bangladesh: Implications for behavior change interventions.
    PLoS One. 2021;16:e0256496.
    >> Share

  53. ALI RN, Rubin H, Sarkar S
    Countering the potential re-emergence of a deadly infectious disease-Information warfare, identifying strategic threats, launching countermeasures.
    PLoS One. 2021;16:e0256014.
    >> Share

  54. ABD ELHAFEEZ S, Elbarazi I, Shaaban R, ElMakhzangy R, et al
    Arabic validation and cross-cultural adaptation of the 5C scale for assessment of COVID-19 vaccines psychological antecedents.
    PLoS One. 2021;16:e0254595.
    >> Share


    Science

  55. MCROBBIE MA
    Colleges must require vaccination.
    Science. 2021;373:945.
    >> Share

  56. LUND FE, Randall TD
    Scent of a vaccine.
    Science. 2021;373:397-399.
    >> Share

  57. THORP HH
    Colleges need vaccine mandates.
    Science. 2021;373:369.
    >> Share

  58. KUPFERSCHMIDT K
    Evolving threat.
    Science. 2021;373:844-849.
    >> Share

  59. WADMAN M
    Israel's grim warning: Delta can overwhelm shots.
    Science. 2021;373:838-839.
    >> Share


    Vaccine

  60. JUNG Y, Min JY, Kim HJ, Min KB, et al
    Disparities in infant mortality from all-infectious, vaccine-preventable, and non-vaccine preventable diseases in relation to parental education.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01012.
    >> Share

  61. AHMED D, VanderEnde K, Harvey P, Bhatnagar P, et al
    Human papillomavirus (HPV) vaccine introduction in Sikkim state: Best practices from the first statewide multiple-age cohort HPV vaccine introduction in India-2018-2019.
    Vaccine. 2021 Aug 21. pii: S0264-410X(21)00901.
    >> Share

  62. DUDLEY MZ, Bernier R, Brewer J, Salmon DA, et al
    Walking the Tightrope: Reevaluating science communication in the era of COVID-19 vaccines.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01070.
    >> Share

  63. ODUWOLE EO, Mahomed H, Laurenzi CA, Larson HJ, et al
    Point-of-care vaccinators' perceptions of vaccine hesitancy drivers: A qualitative study from the cape metropolitan district, South Africa.
    Vaccine. 2021 Aug 24. pii: S0264-410X(21)01102.
    >> Share

  64. ZHANG N, Zheng T, Chen Y, Zhu H, et al
    Coxsackievirus B5 virus-like particle vaccine exhibits greater immunogenicity and immunoprotection than its inactivated counterpart in mice.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01007.
    >> Share

  65. HAUSI H, Nicks P, Mzengeza T, Tsega A, et al
    The challenge of identifying eligible girls for HPV vaccination: HPV mapping data verification in Malawi.
    Vaccine. 2021 Aug 20. pii: S0264-410X(21)00902.
    >> Share

  66. TAYLOR SC, Hurst B, Martiszus I, Hausman MS, et al
    Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination.
    Vaccine. 2021 Aug 6. pii: S0264-410X(21)01013.
    >> Share

  67. PRIVOR-DUMM LA, Poland GA, Barratt J, Durrheim DN, et al
    A global agenda for older adult immunization in the COVID-19 era: A roadmap for action.
    Vaccine. 2021;39:5240-5250.
    >> Share

  68. VENEGAS-VARGAS C, Taylor LP, Foss DL, Godbee TK, et al
    Cellular and humoral immunity following vaccination with two different PCV2 vaccines (containing PCV2a or PCV2a/PCV2b) and challenge with virulent PCV2d.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01033.
    >> Share

  69. OKAMURA S, Ebina H
    Could live attenuated vaccines better control COVID-19?
    Vaccine. 2021 Aug 11. pii: S0264-410X(21)01038.
    >> Share

  70. WIEMKEN TL, Salas J, Hoft DF, Jacobs C, et al
    Dementia risk following influenza vaccination in a large veteran cohort running head: Influenza vaccination and dementia.
    Vaccine. 2021 Aug 19. pii: S0264-410X(21)01079.
    >> Share

  71. NIKOLAY B, Ribeiro Dos Santos G, Lipsitch M, Rahman M, et al
    Assessing the feasibility of Nipah vaccine efficacy trials based on previous outbreaks in Bangladesh.
    Vaccine. 2021 Aug 20. pii: S0264-410X(21)01047.
    >> Share

  72. HUANG XX, Bose AS, Gupta BP, Rai P, et al
    Vaccine preventable diseases surveillance in Nepal: How much does it cost?
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)00915.
    >> Share

  73. KARAFILLAKIS E, Paterson P, Larson HJ
    'My primary purpose is to protect the unborn child': Understanding pregnant women's perceptions of maternal vaccination and vaccine trials in Europe.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01014.
    >> Share

  74. BEDFORD H, Firman N, Waller J, Marlow L, et al
    Which young women are not being vaccinated against HPV? Cross-sectional analysis of a UK national cohort study.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01005.
    >> Share

  75. KOHL-HECKL WK, Schroter M, Dobos G, Cramer H, et al
    Complementary medicine use and flu vaccination - A nationally representative survey of US adults.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01037.
    >> Share

  76. NACIUTE M, Kiwitt T, Kemp RA, Hook S, et al
    Bacteria biohybrid oral vaccines for colorectal cancer treatment reduce tumor growth and increase immune infiltration.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01048.
    >> Share

  77. LEE T, Gutierrez RL, Maciel M, Poole S, et al
    Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.
    Vaccine. 2021 Aug 18. pii: S0264-410X(21)01065.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016